InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Discover the full record of transactions filed by SCHEIBLER LUKAS, Directeur de l'Innovation. Officer active across 1 companies, notably Apellis Pharmaceuticals, Inc.. Cumulatively, 17 filings have been logged. Total volume traded: €405k. The latest transaction was filed on 21 April 2022 (J). Regulator: SEC (Form 4). The full history is free.
Declarations17 total
01,875 shares0
Common Stock
SEC:0001127602-22-016013:0·
€7,734609 shares@ €12.69890.0001% mcap0.7% of flow
Common Stock
SEC:0001127602-22-011670:0·
€44,2163,504 shares@ €12.61860.0008% mcap4.1% of flow
Common Stock
SEC:0001127602-22-011526:0·
€143,79911,496 shares@ €12.50860.0027% mcap13.4% of flow
Common Stock
SEC:0001127602-22-011246:0·
€16,934720 shares@ €23.51950.0003% mcap1.6% of flow
Common Stock
SEC:0001127602-22-005041:0·
€68,3011,666 shares@ €40.99680.0013% mcap6.4% of flow
Common Stock
SEC:0001127602-22-004908:0·
€27,971678 shares@ €41.25540.0005% mcap2.6% of flow
Common Stock
SEC:0001127602-22-004774:0·
€121,03510,000 shares@ €12.10350.0023% mcap31.6% of flow
Common Stock
SEC:0001127602-22-004067·
€121,03510,000 shares@ €12.10350.0023% mcap11.3% of flow
Common Stock
SEC:0001127602-22-004067:0·
€22,225642 shares@ €34.61910.0004% mcap2.1% of flow
Common Stock
SEC:0001127602-22-002804:0·
€22,225642 shares@ €34.61910.0004% mcap5.8% of flow
Common Stock
SEC:0001127602-22-002804·
026,051 shares0
Common Stock
SEC:0001127602-22-002071:0·
026,051 shares0
Common Stock
SEC:0001127602-22-002071·
€71,3743,021 shares@ €23.62610.0014% mcap18.6% of flow
Common Stock
SEC:0001127602-22-001964·
€71,3743,021 shares@ €23.62610.0014% mcap6.6% of flow
Common Stock
SEC:0001127602-22-001964:0·
€168,4283,417 shares@ €49.29120.0032% mcap15.7% of flow
Common Stock
SEC:0001127602-21-019710:0·
€168,4283,417 shares@ €49.29120.0032% mcap44.0% of flow
Common Stock
SEC:0001127602-21-019710·
17 of 17 declarations
About SCHEIBLER LUKAS
Lukas Scheibler is an executive at Apellis Pharmaceuticals, Inc.
